TP-03 (Lotilaner Ophthalmic Solution), 0.25%
TRS-012
Phase 1 small_molecule completed
Quick answer
TP-03 (Lotilaner Ophthalmic Solution), 0.25% for Healthy is a Phase 1 program (small_molecule) at Tarsus Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tarsus Pharmaceuticals
- Indication
- Healthy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed